bioMérieux S.A. (OTCMKTS:BMXMF – Get Free Report) passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $116.05 and traded as low as $110.57. bioMérieux shares last traded at $110.57, with a volume of 9 shares changing hands.
Analysts Set New Price Targets
Separately, UBS Group raised shares of bioMérieux to a “strong-buy” rating in a research report on Thursday, August 22nd.
Check Out Our Latest Analysis on BMXMF
bioMérieux Stock Performance
bioMérieux Company Profile
bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.
Read More
- Five stocks we like better than bioMérieux
- Investing in the High PE Growth Stocks
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- The 3 Best Blue-Chip Stocks to Buy Now
- Breakout Alert: Qualcomm Just Hit The Rally Button
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for bioMérieux Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioMérieux and related companies with MarketBeat.com's FREE daily email newsletter.
